These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11552297)

  • 1. Climbazole is a new potent inducer of rat hepatic cytochrome P450.
    Kobayashi Y; Suzuki M; Ohshiro N; Sunagawa T; Sasaki T; Tokuyama S; Yamamoto T; Yoshida T
    J Toxicol Sci; 2001 Aug; 26(3):141-50. PubMed ID: 11552297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction and inhibition of cytochrome P450 and drug-metabolizing enzymes by climbazole.
    Kobayashi Y; Suzuki M; Ohshiro N; Sunagawa T; Sasaki T; Oguro T; Tokuyama S; Yamamoto T; Yoshida T
    Biol Pharm Bull; 2002 Jan; 25(1):53-7. PubMed ID: 11824557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of 2,4,4'-trichloro-2'-hydroxydiphenyl ether on cytochrome P450 enzymes in the rat liver.
    Hanioka N; Jinno H; Nishimura T; Ando M
    Chemosphere; 1997 Feb; 34(4):719-30. PubMed ID: 9569940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in cytochrome P450 enzymes by 1,1-dichloroethylene in rat liver and kidney.
    Hanioka N; Jinno H; Nishimura T; Ando M
    Arch Toxicol; 1997; 72(1):9-16. PubMed ID: 9458185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction potential of antifungals containing an imidazole or triazole moiety. Miconazole and ketoconazole, but not itraconazole are able to induce hepatic drug metabolizing enzymes of male rats at high doses.
    Lavrijsen K; Van Houdt J; Thijs D; Meuldermans W; Heykants J
    Biochem Pharmacol; 1986 Jun; 35(11):1867-78. PubMed ID: 3013201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selectivity of isoprenoid-containing imidazole antifungal compounds for sterol 14-demethylase P450 (P450(14)DM) and 7-ethoxycoumarin O-deethylase P450 of rat liver microsomes.
    Ito T; Aoyama Y; Ishida K; Kudoh M; Hori K; Tsuchiya S; Yoshida Y
    Biochem Pharmacol; 1994 Oct; 48(8):1577-82. PubMed ID: 7980623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of hepatic microsomal cytochrome P450 and drug-metabolizing enzymes by 4-benzylpyridine and its structurally related compounds in rats. Dose- and sex-related differential induction of cytochrome P450 species.
    Kobayashi Y; Matsuura Y; Kotani E; Iio T; Fukuda T; Aoyagi T; Tobinaga S; Yoshida T; Kuroiwa Y
    Biochem Pharmacol; 1992 May; 43(10):2151-9. PubMed ID: 1599503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Picrotoxin as a potent inducer of rat hepatic cytochrome P450, CYP2B1 and CYP2B2.
    Yamada H; Fujisaki H; Kaneko H; Ishii Y; Hamaguchi T; Oguri K
    Biochem Pharmacol; 1993 May; 45(9):1783-9. PubMed ID: 8494537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in hepatic cytochrome P450 enzymes by cis- and trans-1,2-dichloroethylenes in rat.
    Hanioka N; Jinno H; Nishimura T; Ando M
    Xenobiotica; 1998 Jan; 28(1):41-51. PubMed ID: 9493318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of 4-(4-chlorobenzyl)pyridine on rat hepatic microsomal cytochrome P450 and drug-metabolizing enzymes in vivo and in vitro.
    Kobayashi Y; Ohshiro N; Sasaki T; Tokuyama S; Tobe T; Yoshida T; Yamamoto T
    Biol Pharm Bull; 2001 May; 24(5):505-9. PubMed ID: 11379770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of rociverine on P450-dependent monooxygenases and its N-deethylation metabolism in rat liver microsomes.
    Menicagli S; Lippi A; Criscuoli M; Gervasi PG
    Biochem Pharmacol; 1993 Mar; 45(5):1097-105. PubMed ID: 8461039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of cytochrome P450 inducers on I-compounds in rat liver and kidney DNA.
    Li D; Moorthy B; Chen S; Randerath K
    Carcinogenesis; 1992 Jul; 13(7):1191-8. PubMed ID: 1638686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the effects of risedronate on hepatic microsomal drug metabolizing enzyme activities following administration to rats for 14 days: lack of an induction response.
    Smith BJ; Hu JK; Schwecke WP
    Drug Chem Toxicol; 1998 Aug; 21(3):291-303. PubMed ID: 9706462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microsomal lauric acid hydroxylase activities after treatment of rats with three classical cytochrome P450 inducers and peroxisome proliferating compounds.
    Dirven HA; van den Broek PH; Peters JG; Noordhoek J; Jongeneelen FJ
    Biochem Pharmacol; 1992 Jun; 43(12):2621-9. PubMed ID: 1632818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effects of inducers of cytochrome P450 on Mongolian gerbil and rat hepatic microsomal monooxygenase activities.
    Fentem JH; Fry JR
    Xenobiotica; 1991 Jul; 21(7):895-904. PubMed ID: 1776265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex-related effect of hemin on cytochrome P450 and drug-metabolizing enzymes in rat liver.
    Kobayashi Y; Ohshiro N; Suzuki M; Sasaki T; Tokuyama S; Yoshida T; Yamamoto T
    J Toxicol Sci; 2000 Aug; 25(3):213-22. PubMed ID: 10987129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural requirements for the induction of hepatic microsomal cytochrome P450 by imidazole- and pyridine-containing compounds in rats.
    Kobayashi Y; Matsuura Y; Kotani E; Fukuda T; Aoyagi T; Tobinaga S; Yoshida T; Kuroiwa Y
    J Biochem; 1993 Nov; 114(5):697-701. PubMed ID: 8113223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain mitochondrial cytochromes P450: xenobiotic metabolism, presence of multiple forms and their selective inducibility.
    Bhagwat SV; Boyd MR; Ravindranath V
    Arch Biochem Biophys; 1995 Jun; 320(1):73-83. PubMed ID: 7793987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicity and effects of 2,6-di-tert-butyl-4-methylphenyl N-methylcarbamate (terbutol) on hepatic cytochrome P450 in F344 rats.
    Suzuki T; Nakagawa Y; Tayama K; Yaguchi K; Suga T
    Arch Toxicol; 2001 Nov; 75(9):555-61. PubMed ID: 11760817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo effects of the arylamine human immunodeficiency virus protease inhibitor 4R-(4alpha,5alpha,6beta, 7beta)-1-[(3-(1-imidazoylcarbamoyl)phenyl)methyl]-3-[(3-aminophenyl)m ethyl]hexahydro-5,6-dihydroxy-4,7-bis(phenylmethyl)-2H-1, 3-diazepin-2-one (SD894) on rat hepatic cytochrome P450 2B and 3A.
    Grubb MF; Diamond S; Christ DD
    Drug Metab Dispos; 1997 Dec; 25(12):1424-8. PubMed ID: 9394033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.